Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BGLC NASDAQ:BMGL NASDAQ:MGRX NASDAQ:MRAI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$2.27-5.3%$2.21$1.92▼$15.60$5.50M4.0919,371 shs211,085 shsBMGLBasel Medical Group$0.59+1.6%$0.63$0.49▼$9.40$11.52M0.0732,033 shs15,011 shsMGRXMangoceuticals$0.45-6.2%$0.39$0.16▼$2.75$7.78M2.127.88 million shs253,848 shsMRAIMarpai$0.75-2.2%$0.32$0.22▼$1.78$18.95M4.3865,488 shs279,574 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab+8.11%+19.05%+14.83%-11.76%-23.81%BMGLBasel Medical Group+5.78%+1.61%+0.65%+3.95%-38.82%MGRXMangoceuticals-2.56%+10.27%+34.13%-9.72%-77.11%MRAIMarpai+14.12%+183.19%+196.24%+36.29%-42.94%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$2.27-5.3%$2.21$1.92▼$15.60$5.50M4.0919,371 shs211,085 shsBMGLBasel Medical Group$0.59+1.6%$0.63$0.49▼$9.40$11.52M0.0732,033 shs15,011 shsMGRXMangoceuticals$0.45-6.2%$0.39$0.16▼$2.75$7.78M2.127.88 million shs253,848 shsMRAIMarpai$0.75-2.2%$0.32$0.22▼$1.78$18.95M4.3865,488 shs279,574 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab+8.11%+19.05%+14.83%-11.76%-23.81%BMGLBasel Medical Group+5.78%+1.61%+0.65%+3.95%-38.82%MGRXMangoceuticals-2.56%+10.27%+34.13%-9.72%-77.11%MRAIMarpai+14.12%+183.19%+196.24%+36.29%-42.94%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBGLCBioNexus Gene Lab 1.00SellN/AN/ABMGLBasel Medical Group 1.00SellN/AN/AMGRXMangoceuticals 1.00SellN/AN/AMRAIMarpai 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BGLC, MRAI, BMGL, and MGRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2026BMGLBasel Medical Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/24/2026BMGLBasel Medical Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)3/27/2026MGRXMangoceuticals Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 5/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBGLCBioNexus Gene Lab$7.43M0.74N/AN/A$3.35 per share0.68BMGLBasel Medical Group$8.90M1.25N/AN/A$0.20 per share2.97MGRXMangoceuticals$460K16.91N/AN/A$0.78 per share0.58MRAIMarpai$34.87M0.54N/AN/A($1.72) per share-0.43Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBGLCBioNexus Gene Lab-$2.98M-$1.48N/AN/AN/A-54.70%-37.43%-32.88%N/ABMGLBasel Medical Group-$9.50MN/AN/AN/AN/AN/AN/AN/AN/AMGRXMangoceuticals-$20.64M-$1.49N/AN/AN/A-4,639.13%-112.00%-104.96%N/AMRAIMarpai-$28.75M-$0.87N/AN/AN/A-85.70%N/A-100.23%8/12/2026 (Estimated)Latest BGLC, MRAI, BMGL, and MGRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2026Q1 2026MGRXMangoceuticalsN/A-$0.22N/A-$0.22N/A$0.07 million5/15/2026Q1 2026BGLCBioNexus Gene LabN/A-$0.2250N/A-$0.2250N/A$0.02 million4/14/2026Q4 2025BGLCBioNexus Gene LabN/A-$0.52N/A-$0.5220N/A$0.48 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBGLCBioNexus Gene LabN/AN/AN/AN/AN/ABMGLBasel Medical GroupN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/AMRAIMarpaiN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBGLCBioNexus Gene Lab0.016.535.69BMGLBasel Medical GroupN/AN/AN/AMGRXMangoceuticalsN/A0.290.29MRAIMarpaiN/A0.820.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBGLCBioNexus Gene Lab18.85%BMGLBasel Medical GroupN/AMGRXMangoceuticals56.72%MRAIMarpai49.75%Insider OwnershipCompanyInsider OwnershipBGLCBioNexus Gene Lab0.05%BMGLBasel Medical GroupN/AMGRXMangoceuticals16.00%MRAIMarpai46.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBGLCBioNexus Gene Lab302.42 million2.42 millionNot OptionableBMGLBasel Medical Group3618.79 millionN/AN/AMGRXMangoceuticals317.17 million14.42 millionNot OptionableMRAIMarpai15025.33 million5.61 millionNo DataBGLC, MRAI, BMGL, and MGRX HeadlinesRecent News About These CompaniesMarpai (NASDAQ:MRAI) Trading Up 55.8% - What's Next?May 28 at 2:14 AM | americanbankingnews.comMarpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA ...May 27 at 7:36 PM | tmcnet.comMarpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026May 26 at 4:07 PM | prnewswire.comMARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTSMay 15, 2026 | prnewswire.comMarpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for ProfitabilityMay 11, 2026 | prnewswire.comMarpai Extends Maturity of Insider Promissory NotesMay 1, 2026 | tipranks.comMarpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth NationwideApril 1, 2026 | prnewswire.comMarpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered LivesMarch 9, 2026 | prnewswire.comMarpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform ExpansionFebruary 23, 2026 | prnewswire.comMARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTHJanuary 27, 2026 | prnewswire.comMarpai consolidates leadership as CEO Damien Lamendola becomes PresidentJanuary 23, 2026 | tipranks.comMARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSIONDecember 1, 2025 | prnewswire.comMarpai, Inc. Earnings Call Highlights Mixed SentimentNovember 14, 2025 | msn.comMARPAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTSNovember 12, 2025 | prnewswire.comMarpai Signs Material Definitive AgreementNovember 12, 2025 | tipranks.comMARPAI TO HOST WEBCAST ON NOVEMBER 13, 2025 TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTSNovember 6, 2025 | prnewswire.comMarpai Authorizes 2 Million Blank-Check Preferred SharesOctober 21, 2025 | msn.comMarpai Announces Compliance with Securities Exchange ActOctober 19, 2025 | theglobeandmail.comMARPAI RECOGNIZED AS 2025 TOP THIRD PARTY ADMINISTRATOROctober 14, 2025 | prnewswire.comMARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUNDOctober 6, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBGLC, MRAI, BMGL, and MGRX Company DescriptionsBioNexus Gene Lab NASDAQ:BGLC$2.27 -0.13 (-5.29%) As of 03:41 PM Eastern This is a fair market value price provided by Massive. Learn more.BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Basel Medical Group NASDAQ:BMGL$0.59 +0.01 (+1.56%) As of 03:45 PM Eastern This is a fair market value price provided by Massive. Learn more.Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.Mangoceuticals NASDAQ:MGRX$0.45 -0.03 (-6.21%) As of 03:38 PM Eastern This is a fair market value price provided by Massive. Learn more.Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.Marpai NASDAQ:MRAI$0.75 -0.02 (-2.17%) As of 03:19 PM EasternMarpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys Dollar Tree Keeps Winning After Family Dollar Divorce Salesforce Stock Finds Support as AI Momentum Builds Marvell’s Pullback May Be the Setup Bulls Were Waiting For Snowflake and the Snowballing Impact of its AI Flywheel China Deal Ignites Boeing's Financial Afterburners IREN Is Flipping the Switch from Bitcoin to AI Flight Path to Profits: American Airlines Bets on SpaceX Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
